BrainAurora Medical Technology Limited released its Monthly Return for Equity Issuer for the period ended 30 April 2026, confirming that the company’s share structure remained unchanged during the month.

• Authorised Share Capital The total authorised share capital stood at 500.00 billion ordinary shares with a par value of USD 0.0000001 each, amounting to USD 50,000. No changes were recorded during the month.

• Issued Shares and Treasury Position Issued shares (excluding treasury shares) were unchanged at 1.36 billion. BrainAurora held no treasury shares, and there were no share issuances, cancellations, repurchases or conversions in April.

• Public Float Compliance The company reaffirmed compliance with Hong Kong Main Board Rule 13.32D(1), maintaining a public float of at least 25 % of its issued ordinary shares as required.

• Capital Instruments No activity occurred under share option schemes, warrants, convertible securities or other share-related agreements.

The filing, signed by Director Tan Zheng on 6 May 2026, indicates stability in BrainAurora’s capital structure for the month.